| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/08/2023 | Neoleukin Therapeutics, Inc. | AQXP | Grant | Stock Option (Right to Buy) | 25k | $0.79 | $19.8k | | 06/08/2023 |
| 05/16/2023 | MARINUS PHARMACEUTICALS, INC. | MRNS | Grant | Stock Option (Right to Buy) | 32.4k | $8.51 | $275.7k | | 05/16/2023 |
| 05/16/2023 | MARINUS PHARMACEUTICALS, INC. | MRNS | Grant | Common Stock | 7.2k | $0.00 | $0 | | 05/16/2023 |
| 01/16/2023 | Protagonist Therapeutics, Inc | PTGX | Grant | Stock Option (right to buy) | 30k | $12.17 | $365.1k | | 01/16/2023 |
| 05/26/2022 | Protagonist Therapeutics, Inc | PTGX | Grant | Stock Option (right to buy) | 20k | $8.31 | $166.2k | | 05/26/2022 |
| 05/12/2022 | Neoleukin Therapeutics, Inc. | AQXP | Grant | Stock Option (Right to Buy) | 25k | $1.07 | $26.8k | | 05/12/2022 |
| 05/27/2021 | Protagonist Therapeutics, Inc | PTGX | Grant | Stock Option (right to buy) | 18k | $35.23 | $634.1k | | 05/27/2021 |
| 05/11/2021 | Neoleukin Therapeutics, Inc. | AQXP | Grant | Stock Option (Right to Buy) | 25k | $11.40 | $285k | | 05/11/2021 |
| 05/28/2020 | Protagonist Therapeutics, Inc | PTGX | Grant | Stock Option (right to buy) | 15k | $16.54 | $248.1k | | 05/28/2020 |
| 05/05/2020 | Neoleukin Therapeutics, Inc. | AQXP | Grant | Stock Option (Right to Buy) | 25k | $12.84 | $321k | | 05/05/2020 |
| 10/10/2019 | Neoleukin Therapeutics, Inc. | AQXP | Grant | Stock Option (right to buy) | 22k | $2.82 | $62k | | 10/10/2019 |
| 06/07/2019 | Protagonist Therapeutics, Inc | PTGX | Grant | Stock Option (right to buy) | 12k | $11.80 | $141.6k | | 06/07/2019 |
| 05/29/2018 | Protagonist Therapeutics, Inc | PTGX | Grant | Stock Option (right to buy) | 12k | $6.98 | $83.8k | | 05/29/2018 |
| 12/15/2017 | Protagonist Therapeutics, Inc | PTGX | Grant | Stock Option (right to buy) | 24k | $0.00 | $0 | | 12/15/2017 |
| 12/15/2017 | Protagonist Therapeutics, Inc | PTGX | Grant | Stock Option (right to buy) | 24k | $17.57 | $421.7k | | 12/15/2017 |